International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteePeter F. Ambros, J.M. Maris, Gudrun Schleiermacher et al.|British Journal of Cancer|2009Cited by 404
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectGudrun Schleiermacher, A D Pearson, Véronique Mosseri et al.|British Journal of Cancer|2012Cited by 194
Patterns of Failure After Response-Based, Dose-Dense Therapy for Intermediate/High Risk Pediatric Hodgkin’s Disease (POG 9425)L.S. Constine, Cindy L. Schwartz, Rebecca Marcus et al.|International Journal of Radiation Oncology*Biology*Physics|2005Cited by 6